Identification of novel influenza virus H3N2 nucleoprotein inhibitors using most promising epicatechin derivatives

Tajul Islam Mamun(Sylhet Agricultural University), Jonas Ivan Nobre Oliveira(Universidade Federal do Rio Grande do Norte), Al-Anood M. Al-Dies(Umm al-Qura University), Sharifa Sultana(Daffodil International University), D. Vijay(OSRAM (United States)), Neeraj Kumar(Jamia Hamdard), Ahmed Al‐Emam(Mansoura University), Umberto L. Fulco(Universidade Federal do Rio Grande do Norte), Hesham M. Hassan(King Khalid University), Farjana Islam Aovi(Daffodil International University)
Computational Biology and Chemistry
November 27, 2024
10.1016/j.compbiolchem.2024.108293
Cited by 0

Related Papers

RETRACTED: Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance
|Biomedicine & Pharmacotherapy|2022|149
Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer’s Disease
|Oxidative Medicine and Cellular Longevity|2022|128
Rotenone: from modelling to implication in Parkinson’s disease
|Folia Neuropathologica|2019|124
A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives
|PLoS ONE|2023|48
In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
|Frontiers in Cellular and Infection Microbiology|2022|43